ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

BSA Working Group

November 12, 2010

Niccotine Reports As Aiding Metastasis

August 22, 1986

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Univ. Of Pittsburg distances Itself From Fisher

June 24, 1994